235 related articles for article (PubMed ID: 36538748)
1. PROTAC Degraders of Androgen Receptor-Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration.
Wang R; Zhong T; Bian Q; Zhang S; Ma X; Li L; Xu Y; Gu Y; Yuan A; Hu W; Qin C; Gao J
Small Methods; 2023 Jan; 7(1):e2201293. PubMed ID: 36538748
[TBL] [Abstract][Full Text] [Related]
2. Microneedle Delivery Platform Integrated with Codelivery Nanoliposomes for Effective and Safe Androgenetic Alopecia Treatment.
Zhang S; Zhou H; Chen X; Zhu S; Chen D; Luo D; Chen S; Liu W
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15701-15717. PubMed ID: 38507687
[TBL] [Abstract][Full Text] [Related]
3. Ceria Nanozyme-Integrated Microneedles Reshape the Perifollicular Microenvironment for Androgenetic Alopecia Treatment.
Yuan A; Xia F; Bian Q; Wu H; Gu Y; Wang T; Wang R; Huang L; Huang Q; Rao Y; Ling D; Li F; Gao J
ACS Nano; 2021 Aug; 15(8):13759-13769. PubMed ID: 34279913
[TBL] [Abstract][Full Text] [Related]
4. Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis.
Yuan A; Gu Y; Bian Q; Wang R; Xu Y; Ma X; Zhou Y; Gao J
J Control Release; 2022 Oct; 350():204-214. PubMed ID: 35961471
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia.
Li P; Sun Y; Nie L; Shavandi A; Yunusov KE; Hua Y; Jiang G
Int J Biol Macromol; 2023 Sep; 249():126013. PubMed ID: 37517761
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of androgenetic alopecia.
Crabtree JS; Kilbourne EJ; Peano BJ; Chippari S; Kenney T; McNally C; Wang W; Harris HA; Winneker RC; Nagpal S; Thompson CC
Endocrinology; 2010 May; 151(5):2373-80. PubMed ID: 20233794
[TBL] [Abstract][Full Text] [Related]
7. Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model.
Kim MJ; Seong KY; Kim DS; Jeong JS; Kim SY; Lee S; Yang SY; An BS
Acta Biomater; 2022 Apr; 143():189-202. PubMed ID: 35202857
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia.
Moon IJ; Yoon HK; Kim D; Choi ME; Han SH; Park JH; Hong SW; Cho H; Lee DK; Won CH
Mol Pharm; 2023 Jan; 20(1):128-135. PubMed ID: 36352823
[TBL] [Abstract][Full Text] [Related]
9. Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia.
Premanand A; Reena Rajkumari B
Arch Dermatol Res; 2018 Jul; 310(5):391-399. PubMed ID: 29549490
[TBL] [Abstract][Full Text] [Related]
10. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
[TBL] [Abstract][Full Text] [Related]
11. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
12. Dissolving Microneedle Patch Integrated with Microspheres for Long-Acting Hair Regrowth Therapy.
Yin M; Zeng Y; Liu HQ; Zhang W; Wang C; Chen C; Li W
ACS Appl Mater Interfaces; 2023 Apr; 15(14):17532-17542. PubMed ID: 36975753
[TBL] [Abstract][Full Text] [Related]
13. An androgenetic alopecia remedy based on marine collagen peptide-incorporated dissolving microneedles.
Zheng W; Wang F; Tao N; Wang X; Jin X; Zhang C; Xu C
Int J Pharm; 2024 Jan; 650():123629. PubMed ID: 37992979
[TBL] [Abstract][Full Text] [Related]
14. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
15. Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment.
Ding YW; Li Y; Zhang ZW; Dao JW; Wei DX
Bioact Mater; 2024 Aug; 38():95-108. PubMed ID: 38699241
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia.
Yan A; Ruan R; Zhu X; Qiang W; Guan Y; Yu Q; Sun H; Liu M; Zhu H
Int J Pharm; 2023 Nov; 646():123498. PubMed ID: 37820942
[TBL] [Abstract][Full Text] [Related]
17. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
18. Targeting androgen receptor degradation with PROTACs from bench to bedside.
Jia X; Han X
Biomed Pharmacother; 2023 Feb; 158():114112. PubMed ID: 36508999
[TBL] [Abstract][Full Text] [Related]
19. The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia.
Li K; Sun Y; Liu S; Zhou Y; Qu Q; Wang G; Wang J; Chen R; Fan Z; Liu B; Li Y; Mao X; Hu Z; Miao Y
Int J Biol Sci; 2023; 19(11):3307-3323. PubMed ID: 37496996
[TBL] [Abstract][Full Text] [Related]
20. Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia.
Richeti F; Kochi C; Rocha MN; Sant'Anna Corrêa C; Lazzarini R; Guazzelli RM; Mendonça RF; Melo MR; Longui CA
Genet Mol Res; 2013 Jun; 12(2):1834-40. PubMed ID: 23479164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
